Last updated on 18 Feb 2025
Owner Info
Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BELGIUM
Serial Number
2504278 filed on 6 Nov 2024
Correspondent
JOHNSON & JOHNSON
One Johnson & Johnson Plaza,
New Brunswick, NJ 08933,
UNITED STATES OF AMERICA
2504278
6 Nov 2024
6 Nov 2034
WORD
10 Jun 2024
BX
Status Date | Action Taken |
---|---|
18th Feb 2025 | International Registration in Australia Protected correspondence sent |
17th Feb 2025 | IP Right Registration Published |
17th Feb 2025 | Status change to Registered/Protected |
11th Dec 2024 | Application Accepted correspondence sent |
10th Dec 2024 | IP Right has been Examined |
10th Dec 2024 | IP Right Acceptance Published |
10th Dec 2024 | Status change to Accepted |
10th Dec 2024 | Examination expedited |
10th Dec 2024 | Awaiting examination |
5th Dec 2024 | IP Right Filed Published |